The government of the United Kingdom announced Wednesday that it was placing an “emergency ban” on the private prescription and supply of puberty blockers for minors, according to a press release.
Both England and Scotland announced in March and April, respectively, that they were halting puberty blocker treatments for new patients under the age of 18 due to concerns about side effects and the largely unknown long-term impacts.
The government announced that from June 3 to Sept. 3 private prescribers in England, Wales, and Scotland, as well as “prescribers registered in the European Economic Area (EEA) or Switzerland,” will not be able to offer puberty blockers as a treatment for minors with gender dysphoria, according to the new regulations.
“During this period no new patients under 18 will be prescribed these medicines for the purposes of puberty…
